CASP3-1-E |
Caspase-3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.20 |
Binding ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
810 |
0.20 |
Binding ≤ 10μM |
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
810 |
0.20 |
Binding ≤ 10μM |
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
25 |
0.25 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
25 |
0.25 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
25 |
0.25 |
Functional ≤ 10μM
|
Z100733-1-O |
CT26 (Colon Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
200 |
0.22 |
Functional ≤ 10μM
|
Z100752-1-O |
Renca (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2900 |
0.18 |
Functional ≤ 10μM
|
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
3920 |
0.18 |
Functional ≤ 10μM
|
Z103204-2-O |
A427 (cluster #2 Of 4), Other |
Other |
130 |
0.23 |
Functional ≤ 10μM
|
Z103413-1-O |
SW948 (cluster #1 Of 1), Other |
Other |
1300 |
0.20 |
Functional ≤ 10μM
|
Z50425-1-O |
Plasmodium Falciparum (cluster #1 Of 22), Other |
Other |
5012 |
0.18 |
Functional ≤ 10μM
|
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
990 |
0.20 |
Functional ≤ 10μM
|
Z80008-1-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
530 |
0.21 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
2150 |
0.19 |
Functional ≤ 10μM
|
Z80026-1-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
360 |
0.21 |
Functional ≤ 10μM |
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
9000 |
0.17 |
Functional ≤ 10μM
|
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
2 |
0.29 |
Functional ≤ 10μM
|
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
1200 |
0.20 |
Functional ≤ 10μM
|
Z80068-1-O |
CCRF-SB (Lymphoblastic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
100 |
0.23 |
Functional ≤ 10μM
|
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
350 |
0.22 |
Functional ≤ 10μM
|
Z80112-1-O |
DAN-G (cluster #1 Of 2), Other |
Other |
380 |
0.21 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
5160 |
0.18 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
970 |
0.20 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
750 |
0.20 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
6600 |
0.17 |
Functional ≤ 10μM
|
Z80179-1-O |
J82 (Bladder Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
800 |
0.20 |
Functional ≤ 10μM |
Z80186-9-O |
K562 (Erythroleukemia Cells) (cluster #9 Of 11), Other |
Other |
522 |
0.21 |
Functional ≤ 10μM
|
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
567 |
0.21 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
834 |
0.20 |
Functional ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
2300 |
0.19 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
878 |
0.20 |
Functional ≤ 10μM
|
Z80244-4-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #4 Of 7), Other |
Other |
600 |
0.21 |
Functional ≤ 10μM
|
Z80284-3-O |
MOLT-3 (T-lymphoblastic Leukemia Cells) (cluster #3 Of 3), Other |
Other |
65 |
0.24 |
Functional ≤ 10μM
|
Z80285-1-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #1 Of 4), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM |
Z80288-1-O |
MOVP-3 (cluster #1 Of 1), Other |
Other |
7550 |
0.17 |
Functional ≤ 10μM
|
Z80295-6-O |
MT4 (Lymphocytes) (cluster #6 Of 8), Other |
Other |
1250 |
0.20 |
Functional ≤ 10μM
|
Z80322-2-O |
NCI-H358 (Lung Carcinama Cells) (cluster #2 Of 2), Other |
Other |
1500 |
0.19 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
50 |
0.24 |
Functional ≤ 10μM
|
Z80390-2-O |
PC-3 (Prostate Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
7800 |
0.17 |
Functional ≤ 10μM
|
Z80435-1-O |
RT-112 (cluster #1 Of 1), Other |
Other |
220 |
0.22 |
Functional ≤ 10μM
|
Z80436-1-O |
RT-4 (cluster #1 Of 1), Other |
Other |
1330 |
0.20 |
Functional ≤ 10μM
|
Z80473-1-O |
SISO (cluster #1 Of 2), Other |
Other |
150 |
0.23 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
300 |
0.22 |
Functional ≤ 10μM
|
Z80482-1-O |
SK-MEL-2 (Melanoma Cells) (cluster #1 Of 4), Other |
Other |
5720 |
0.17 |
Functional ≤ 10μM
|
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
850 |
0.20 |
Functional ≤ 10μM
|
Z80490-3-O |
SK-MES-1 (cluster #3 Of 4), Other |
Other |
2500 |
0.19 |
Functional ≤ 10μM
|
Z80491-2-O |
SK-N-MC (Neuroepithelioma Cells) (cluster #2 Of 4), Other |
Other |
275 |
0.22 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
4900 |
0.18 |
Functional ≤ 10μM
|
Z80546-1-O |
TERT-RPE1 (Retinal Pigmented Epithelial Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.23 |
Functional ≤ 10μM
|
Z80548-4-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #4 Of 5), Other |
Other |
2160 |
0.19 |
Functional ≤ 10μM
|
Z80559-1-O |
U251 (cluster #1 Of 3), Other |
Other |
500 |
0.21 |
Functional ≤ 10μM
|
Z80600-2-O |
XF498 (Glioma Cells) (cluster #2 Of 2), Other |
Other |
3480 |
0.18 |
Functional ≤ 10μM
|
Z80601-1-O |
XRS6 (cluster #1 Of 1), Other |
Other |
140 |
0.23 |
Functional ≤ 10μM
|
Z80604-1-O |
YAPC (cluster #1 Of 2), Other |
Other |
1320 |
0.20 |
Functional ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
240 |
0.22 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
9980 |
0.17 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
160 |
0.23 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
3667 |
0.18 |
Functional ≤ 10μM |
Z80846-1-O |
F460pv8/eto Cell Line (cluster #1 Of 2), Other |
Other |
740 |
0.20 |
Functional ≤ 10μM
|
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
591 |
0.21 |
Functional ≤ 10μM
|
Z80866-1-O |
GLC4 Cell Line (cluster #1 Of 1), Other |
Other |
820 |
0.20 |
Functional ≤ 10μM
|
Z80889-1-O |
NCI-H322M (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
1590 |
0.19 |
Functional ≤ 10μM
|
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
1192 |
0.20 |
Functional ≤ 10μM
|
Z80901-1-O |
HaCaT (Keratinocytes) (cluster #1 Of 2), Other |
Other |
550 |
0.21 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
9500 |
0.17 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
4900 |
0.18 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
90 |
0.23 |
Functional ≤ 10μM
|
Z81043-1-O |
N592 (cluster #1 Of 2), Other |
Other |
500 |
0.21 |
Functional ≤ 10μM
|
Z81054-1-O |
SF-268 (Glioblastoma Cells) (cluster #1 Of 3), Other |
Other |
3250 |
0.18 |
Functional ≤ 10μM
|
Z81065-1-O |
IGROV-1 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
985 |
0.20 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
160 |
0.23 |
Functional ≤ 10μM
|
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 6), Other |
Other |
800 |
0.20 |
Functional ≤ 10μM
|
Z81126-1-O |
KYSE-150 Cell Line (cluster #1 Of 1), Other |
Other |
700 |
0.21 |
Functional ≤ 10μM
|
Z81128-1-O |
KYSE-520 Cell Line (cluster #1 Of 1), Other |
Other |
410 |
0.21 |
Functional ≤ 10μM
|
Z81130-1-O |
KYSE-70 Cell Line (cluster #1 Of 1), Other |
Other |
790 |
0.20 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
180 |
0.22 |
Functional ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
577 |
0.21 |
Functional ≤ 10μM |
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
8930 |
0.17 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
700 |
0.21 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
240 |
0.22 |
Functional ≤ 10μM
|
Z81284-1-O |
NCI-H647 (cluster #1 Of 2), Other |
Other |
80 |
0.24 |
Functional ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
900 |
0.20 |
Functional ≤ 10μM
|
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 4), Other |
Other |
300 |
0.22 |
ADME/T ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
3930 |
0.18 |
ADME/T ≤ 10μM
|